Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One power score. Smarter investment decisions
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
BREAKINGVIEWS-Big Pharma’s tariff win leaves lingering aches
By Aimee DonnellanDUBLIN, Sept 26 (Reuters Breakingviews) - President Donald Trump has unleashed 100% levies on branded drugs, unless they’re made locally. US factory-building by the likes of AstraZeneca now looks smart. But the lower multiples at which sector players trade signal valid concern abo...
Reuters
8 minutes ago
Perpetua in talks with Glencore, others for US antimony processing; shares rise
** Shares of mining company Perpetua Resources PPTA.O rise 3.1% to $19.58 premarket** Co says it is in talks with Glencore GLEN.L, TrafiguraTRAFG.UL, Clarios and Sunshine Silver about partnership to refine antimony in U.S.** PPTA plans to seek proposals in coming weeks, with decision expected by end...
Reuters
9 minutes ago
US pharma stocks mostly firm after Trump tariffs
** Shares of major U.S. drugmakers were mostly stable or marginally up after President Donald Trump announced 100% tariffs on branded drugs imported by firms that are not building plants in U.S.** Shares of Abbvie ABBV.N, Merck MRK.N and Eli Lilly LLY.N were up 1% premarket** Shares of Amgen AMGN.O,...
Reuters
13 minutes ago
Fractyl Health gains as experimental procedure helps maintain weight-loss in study
** Shares of drug developer Fractyl Health GUTS.O rise 24.7% to $1.26 before the bell** Co says patients treated with its experimental lead product Revita preserved weight loss after GLP-1 drug discontinuation** Revita is an outpatient endoscopic procedure designed to modify dysfunction in the part...
Reuters
23 minutes ago
Fractyl Health says experimental procedure helps maintain weight-loss in study
Sept 26 (Reuters) - Fractyl Health GUTS.O said its experimental outpatient procedure helped preserve weight loss after discontinuation of a GLP-1 drug, sending the company's shares 23% higher in premarket trading on Friday.The company was testing the efficacy of its experimental outpatient proce...
Reuters
27 minutes ago
Is There a Future for XRP?
Key PointsXRP is a bridge currency and provides on-demand liquidity for cross-border payments through RippleNet.While over 300 banks use RippleNet, few use XRP.That will need to change for this cryptocurrency to continue to grow.10 stocks we like better than XRP › After spending years below $1, XRP ...
The Motley Fool
32 minutes ago
Concord Medical Reports Financial Results for the First Half of 2025
BEIJING, Sept. 26, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced its unaudited consolid...
PR Newswire
32 minutes ago
Pre-Bell|Wall Street Futures Mixed Ahead Inflation Data; Intel Rose 4%; Wolfspeed Tumbled 25%; Concentrix Tumbled 20%
U.S. stock index futures were mixed on Friday, as investors awaited key inflation data that could sway bets on interest rate cuts, while also weighing the impact of fresh tariffs on a broad range of imported goods.Market SnapshotAt 07:22 a.m. ET, Dow E-minis were up 38 points, or 0.08%, S&P 500 E-mi...
Tiger News
34 minutes ago
J.P. Morgan starts Valmont at 'overweight' on growth tailwinds
** Shares of irrigation equipment provider Valmont Industries VMI.N modestly up at $364.66 in premarket** J.P. Morgan initiates coverage on the stock with an "overweight" rating and price target of $480** Brokerage says VMI is uniquely positioned at the intersection of infrastructure and agr...
Reuters
38 minutes ago
Wall Street futures mixed as investors brace for inflation data
Sept 26 (Reuters) - U.S. stock index futures were mixed on Friday, as investors awaited key inflation data that could sway bets on interest rate cuts, while also weighing the impact of fresh tariffs on a broad range of imported goods.
Reuters
39 minutes ago
Trump signs order declaring TikTok sale ready and values it at $14 billion
Trump says China's Xi has said to go ahead with the dealDeal valued at $14 billion, Vice President JD Vance saysTrump says Michael Dell, Rupert Murdoch among investorsOracle, Silver Lake among owners of 50% share of TikTok US, sources sayBy Jeff Mason, Dawn Chmielewski and David Shepardson WA...
Reuters
40 minutes ago
Could This Single Dividend King Make Your Portfolio Worth $1 Million in 20 Years?
Key PointsJohnson & Johnson's streak of dividend growth and its business prospects make the stock attractive.However, making millionaires in 20 years is a tall order. Even if the company can't pull it off, the stock is a good pick for long-term dividend seekers. 10 stocks we like better than Johnson...
The Motley Fool
41 minutes ago
IBM Just Made a Quantum Computing Breakthrough
Key PointsHSBC used IBM's quantum computers to improve a process involved in algorithm bond trading.The collaboration demonstrated that pairing quantum computers with classical techniques can provide real-world benefits.IBM's long-term quantum computing opportunity is enormous, and this development ...
The Motley Fool
42 minutes ago
Mirion Technologies gains after boosted stock, convertible offerings for M&A
** Shares of radiation detection firm Mirion Technologies MIR.N up 3.1% premarket to $22.10 after above-target M&A-related capital raise** Mirion early Fri announced pricing ~17.3 mln shares at $21.35 for about $369.6 mln gross raise, and said it priced private offering of $325 mln 0% convertibl...
Reuters
42 minutes ago
Is O'Reilly Auto Parts Stock a Buy?
Key PointsO’Reilly’s stock has more than tripled in the past five years. The current valuation is very expensive from a historical perspective. This is a high-quality company that should be on investors’ watch lists. 10 stocks we like better than O'Reilly Automotive › O'Reilly Automotive (NASDAQ: O...
The Motley Fool
47 minutes ago
1 High-Yield Vanguard Dividend Fund to Buy Hand Over Fist
Key PointsThe Vanguard Real Estate ETF provides exposure to a diverse portfolio of REITs.Real estate has dramatically underperformed the S&P 500 over the past decade.Lower interest rates could help create an inflection point. 10 stocks we like better than Vanguard Real Estate ETF › Vanguard offers d...
The Motley Fool
50 minutes ago
Baird cuts PT on Klaviyo citing omission of revenue target
** Baird cuts PT on marketing automation platform Klaviyo KVYO.N to $39 from $45, retains "outperform" rating** Brokerage says company has strong growth potential operating in areas like customer experience and artificial intelligence, however absence of revenue guidance has raised eyebrows*...
Reuters
52 minutes ago
This Surprising Cruise Line Stock Is Beating the Market in 2025. Time to Buy?
Key PointsCarnival is set to match record bookings, as it fills available cabins beyond 100% capacity.Its debt burden from the pandemic continues to weigh on the company.But total debt levels continue to fall.10 stocks we like better than Carnival Corp. › Carnival Corporation (NYSE: CCL) is often ov...
The Motley Fool
an hour ago
Trump's tariff move weighs on Asian drugmakers; European shares steady
Analysts expect Asian drugmakers' focus on generics to limit impactJapan says its trade deal will keep pharma tariffs competitive with EUTariffs had already been reflected in company valuationsBy Gregor Stuart Hunter and Andrew Silver SINGAPORE/SHANGHAI, Sept 26 (Reuters) - Shares of Euro...
Reuters
an hour ago
Rapt Therapeutics climbs after Leerink Partners upgrades to 'outperform'
** Shares of drug developer Rapt Therapeutics RAPT.O rise 4% to $25.42 premarket** Brokerage Leerink Partners upgrades stock to "outperform" from "market perform," citing favorable outlook for lead drug RPT904, which is being developed to treat allergic diseases** Brokerage also rais...
Reuters
an hour ago
1
1
/
4290
2
3
4
5
...
4290
next page
KeyAI
Please log in to use KeyAI
Log in
Sign Up